Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1–Risk Myelodysplastic Syndromes: A Randomized Trial
Year: 2020
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Internal Medicine
DOI: 10.7326/m19-0916
Authors: Emanuele Angelucci, Junmin Li, Peter Greenberg, Depei Wu, Ming Hou, Efreen Horacio Montaňo Figueroa, Maria Guadalupe Rodriguez, Xunwei Dong, Jagannath Ghosh, Miguel Izquierdo, Guillermo Garcia-Manero, on behalf of the TELESTO Study Investigators*
Institutions: Ospedale Policlinico San Martino, Shanghai Jiao Tong University, Ruijin Hospital, Stanford Medicine, First Affiliated Hospital of Soochow University, Shandong University, Qilu Hospital of Shandong University, Hospital General de México, Mexican Social Security Institute, Centro Médico Nacional La Raza, Novartis (Switzerland), The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3012730855
